Cannabis
Tilray Keeps Growing Revenue, Can’t Cut Losses in Q4 Earnings Report
Yesterday, Tilray Inc. (NASDAQ:TLRY) reported its Q4 earnings. Rich went live with the earnings call, and today we’re following up with a break-down and some post-report analysis. Rich last profiled Tilray in November, after its Q3 ... [Read]
Cannabis
Tilray (NASDAQ:TLRY) Beat Revenue, So Why Did It Miss on Earnings?
Yesterday, Rich discussed the Q3 earnings from MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF). Always a leader in the sector, MediPharm posted some big numbers, particularly in revenue. Today, it’s Tilray Inc.’s (NASDAQ:TLRY) turn to report earnings from its third ... [Read]